Q&A with FDA: Recent Episodes
U.S. Food and Drug Administration, Center for Drug Evaluation and Research
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
In this episode of the Q&A with FDA podcast, learn about Understanding Drug Recalls with Dr. Ileana Elder in the Office of Compliance.
In this episode of the Q&A with FDA podcast, learn about Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim from FDA’s Office of Generic Drugs.
In this episode of the Q&A with FDA podcast, learn about real world evidence, real world data, and how FDA continues to advance clinical trials and promote reliable evidence to support the safety and effectiveness of drug products with Dr. Hilary Marston, FDA’s Chief Medical Officer.
Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.
Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
Listen to our latest podcast series, Q&A with FDA, on Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng.
Listen to our latest podcast series, Q&A with FDA - FDA’s Regulation of Dietary Supplements featuring Dr. Cara Welch.
Listen to our latest podcast series, Q&A with FDA, on A Step Forward in the Treatment of Opioid and Alcohol Dependence featuring Dr. Iilun Murphy and Dr. Marta Sokolowska.
FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska
In this podcast series, we answer some of the most frequently asked questions we’ve received from the public.
In today’s episode, we’ll be discussing Paxlovid, which is now widely available in community pharmacies.